Form 8-K Moleculin Biotech, Inc. For: Dec 20

Related Keywords

Houston ,Texas ,United States ,Warszawa ,L67 ,Poland ,Madagascar ,Kazakhstan ,Vanuatu ,Niger ,Brazil ,Belarus ,Moldova ,Burundi ,Czech Republic ,Sao Tome ,Sãtomés ,Sao Tome And Principe ,Nicaragua ,Netherlands ,Sudan ,Zimbabwe ,Ghana ,Papua New Guinea ,Senegal ,Tajikistan ,Saint Lucia ,Bissau ,Guinea Bissau ,Kiribati ,Djibouti ,Azerbaijan ,Argentina ,Cook Islands ,Liberia ,Ivoire ,Ouest ,Haiti ,United Arab Emirates ,Togo ,Fiji ,Gambia ,Iraq ,Mali ,Denmark ,Costa Rica ,Paraguay ,Gabon ,Swaziland ,Sweden ,Chile ,Cabo Verde ,Piauhy ,Lithuania ,Turkey ,Bhutan ,Sierra Leone ,Mauritania ,China ,Yemen ,Jamaica ,Austria ,Zambia ,Harris County ,Woman ,Ukraine ,Montenegro ,Nigeria ,Turkmenistan ,Cambodia ,Kuwait ,Morocco ,Ireland ,Marshall Islands ,Switzerland ,Monaco ,Georgia ,Malaysia ,Philippines ,Trinidad And Tobago ,Iran ,Dominica ,Seychelles ,Congo ,State Of Texas ,Luxembourg ,Indonesia ,Tonga ,Canada ,University Of Texas ,Bangladesh ,Estonia ,Maldives ,Croatia ,Belgium ,Albania ,Niue ,Peru ,Bahamas ,The ,Latvia ,Qatar ,Afghanistan ,Brunei ,San Marino ,Angola ,Mozambique ,Mexico ,Malawi ,Egypt ,Nepal ,Suriname ,Guinea ,Ecuador ,Uruguay ,Finland ,Micronesia ,Spain ,Norway ,Japan ,Saint Vincent And The Grenadines ,Algeria ,Bolivia ,El Salvador ,Saint Kitts ,Kwazulu Natal ,South Africa ,Antigua And Barbuda ,Guatemala ,Uganda ,Slovakia ,Abuz Aby ,Pakistan ,Tunisia ,Namibia ,Thailand ,Hungary ,Palau ,Singapore ,Dominican Republic ,Slovenia ,Cameroon ,Central African Republic ,Saudi Arabia ,Guyana ,France ,Serbia ,Malta ,Honduras ,Australia ,Burkina Faso ,Mongolia ,Chad ,United Kingdom ,Lesotho ,Mauritius ,Portugal ,Tanzania ,Russia ,Sri Lanka ,Bahrain ,Ethiopia ,South Sudan ,Iceland ,India ,New Zealand ,Botswana ,Italy ,Samoa ,Panama ,South Korea ,Greece ,Kyrgyzstan ,Armenia ,Uzbekistan ,Lebanon ,Comoros ,Eritrea ,East Timor ,Rwanda ,Tuvalu ,Colombia ,Grenada ,Belize ,Solomon Islands ,Jordan ,Nauru ,Germany ,Benin ,Andorra ,Kenya ,Israel ,Equatorial Guinea ,Bulgaria ,Barbados ,Cyprus ,Romania ,United Republic Of Tanzania ,Saint Vincent ,Republic Of Korea ,Trinidad ,Antigua ,Republic Of Moldova ,Brunei Darussalam ,America ,Russian Federation ,Polish ,Timor ,Mariusz Olejiczak ,Jenene Thomas ,Ryan Cravey ,Walter Klemp ,Viet Nam ,Mariusz Olejniczak ,Plurinational States ,Majeure Event ,Third Party Indemnity ,Moleculin Biotech Inc ,Linkedin ,Twitter ,Development Plan ,Technology Development ,Annamed Inc ,Eastern Cooperative Oncology Group ,Nasdaq ,Reasonable Development Efforts ,European Union ,Facebook ,Prnewswire Moleculin Biotech Inc ,A Party ,Drug Administration ,Intertech Bio Corporation ,Pharmaceuticals Sp ,Party Indemnity ,Technology License Agreement ,Exchange Commission ,Technology Rights ,Development Data ,Securities Exchange ,License Agreements ,Licensed Products ,Licensed Territory ,Licensed Field ,Patent Rights ,Sublicensed Products ,Sublicensed Subject Matter ,Sublicensed Field ,Sublicensed Territories ,Calendar Quarter ,Effective Date ,Calendar Year ,Reasonable Development ,Securities Exchange Act ,License Agreement ,Intertech Bio ,Sublicensed Product ,Assumption Agreement ,Sublicensed Territory ,Sublicensed Patent Rights ,Sublicensed Technology Rights ,Cancer Center ,Commercially Reasonable Development Efforts ,First Extension Fee ,Second Extension Fee ,Third Extension ,Buyback Event ,World Healthcare Spend ,Qualified Buyback Event ,Qualified Counteroffer ,Buy Back Event Notification ,Buyback Event Notification ,Qualified Buyback ,Marketing Approval ,Annual Development Plan ,Grant Guarantees ,Commercially Reasonable Development ,Beach Party ,Joint Funding ,Chief Financial Officer ,Board Observer ,Initial Hurdle Date ,Dermin License Agreements ,Annual Development ,Required Extension Fee ,Net Sales ,Minimum Annual Royalties ,Minimum Annual Royalty ,Market Approval ,Regulatory Approval ,Additional Patent ,Additional Patents ,Annual Maintenance Fee ,Dermin License ,Sublicensed Subject ,Corrupt Practices Act ,Indemnified Party ,Indemnifying Party ,Third Party Indemnity Claim ,Confidential Information ,Licensed Subject Matter ,European Union General Data Protection Regulation ,Personal Data ,Privacy Laws ,Sublicensed Patents ,Sublicensed Patent ,First Refusal ,Buyback Consideration ,Buyback Percentage ,Buyback Territory Percentage ,Federal Express ,Force Majeure Event ,Verde Republic ,Federated States ,Yugoslav Republic ,Bolivarian Republic ,Moleculin Biotech ,Sublicense Agreement ,Prevent Default ,Consent Agreement ,Default Notice ,Assignment Date ,Objection Expiration Date ,Objection Notice ,Common Stock ,Termination Notice ,Termination Fee ,Moleculin Common Stock ,Upon Assignment ,Announces Preliminary Third Cohort Interim Data ,Soft Tissue Sarcoma Lung ,Fast Track Status ,Orphan Drug Designation ,Salvage Therapy ,Advanced Adult Soft Tissue Sarcoma ,Systematic Review ,Randomized Trials ,Transcription Modulator ,Securities Act ,Private Securities Litigation Reform Act ,Although Moleculin ,